- Taro Pharmaceuticals recalls epilepsy drug
Taro Pharmaceuticals, a Hawthorne, N.Y.-based drugmaker, is recalling one lot of its drugs, Lamotrigine, designed to treat epilepsy and bipolar disorder, after discovering it was cross-contaminated with a small amount of another drug substance. - Mavidon updates recall of skin prep lotion after bacterial contamination found
Mavidon is updating a worldwide recall of its skin-prepping lotions to include all lots of the products after discovering a bacterial contamination that could cause life-threatening infections. - Mylan recalls ulcer treatment after carcinogen found
Mylan is recalling three lots of its ulcer treatment after detecting trace amounts of a carcinogen in the product. - Aurobindo Pharma recalls antidepressant with mislabeled dosage
Generic drugmaker Aurobindo Pharma USA is recalling its antidepressant drug Mirtazapine because of a labeling error.
More articles on pharmacy:
Roche pulled a $1.5B fast one on US, whistleblower physician alleges
CVS adds 15 HealthHUBs to Houston area
Nationwide Children’s to build gene therapy biofactory, create more than 100 jobs
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.